What is the recommended oral (PO) vancomycin dosage for an adult with Clostridioides difficile infection?

Oral Vancomycin Dosing for C. difficile Infection

For initial C. difficile infection, use oral vancomycin 125 mg four times daily for 10 days 1, 2.

Dosing by Clinical Scenario

Initial CDI Episode

• Standard dose: 125 mg PO four times daily for 10 days 1
• This applies to both severe and non-severe disease
• Fidaxomicin is preferred if resources allow, but vancomycin remains an acceptable alternative 1

Fulminant CDI

• High dose: 500 mg PO four times daily 1
• Administer by mouth or nasogastric tube
• If ileus present, add rectal vancomycin instillation
• Must combine with IV metronidazole 500 mg every 8 hours 1
• Fulminant disease defined by: hypotension/shock, ileus, or megacolon 1

First Recurrence

• Tapered/pulsed regimen (preferred alternative): 125 mg four times daily for 10-14 days, then twice daily for 7 days, then once daily for 7 days, then every 2-3 days for 2-8 weeks 1
• Standard 125 mg four times daily for 10 days is acceptable if metronidazole was used initially 1

Second or Subsequent Recurrence

• Same tapered/pulsed vancomycin regimen as above, OR
• 125 mg four times daily for 10 days followed by rifaximin 400 mg three times daily for 20 days 1

Evidence Supporting 125 mg Dosing

The 125 mg dose is as effective as higher doses for non-fulminant disease. Multiple studies demonstrate equivalency:

• A 1989 randomized trial showed no difference between 125 mg and 500 mg four times daily—both achieved resolution in approximately 4 days with 20% recurrence rates 3
• A 2021 dual-center study (535 patients) found no differences in recurrence, clinical failure, mortality, or readmission between standard (125 mg) and high-dose (≥250 mg) vancomycin 4
• A 2021 retrospective cohort demonstrated equivalency between low-dose (125 mg) and high-dose vancomycin with similar cure rates 5
• A 2013 study of severe CDI showed 64% cure rate with ≤500 mg daily versus 60% with >500 mg daily (not significant) 6

Critical Caveats

Do not use higher doses routinely. The evidence is clear that 125 mg achieves fecal concentrations 3 orders of magnitude above the MIC90 for C. difficile 7. Higher doses:

• Provide no additional clinical benefit for non-fulminant disease 3, 4, 5, 6
• Increase cost unnecessarily
• May increase VRE colonization risk (50% vs 24% in one study) 8, 9

Exception: Fulminant disease requires 500 mg four times daily as per IDSA/SHEA guidelines 1.

Monitor renal function in patients >65 years, as nephrotoxicity can occur with oral vancomycin, particularly in elderly patients 2. Systemic absorption can occur with inflamed intestinal mucosa 2.

Pediatric dosing (<18 years): 40 mg/kg/day divided into 3-4 doses for 7-10 days, not to exceed 2 g daily 2.

Practical Algorithm

1. Determine disease severity:

   • Fulminant (hypotension, ileus, megacolon)? → 500 mg QID + IV metronidazole
   • Initial episode or first recurrence? → 125 mg QID for 10 days
   • Multiple recurrences? → Tapered/pulsed regimen

2. Monitor for complications:

   • Age >65: Check renal function during and after treatment
   • Inflammatory bowel disease or severe colitis: Consider monitoring vancomycin levels

3. Do not escalate dose unless fulminant disease develops